Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Biorce’s Aika represents a groundbreaking AI-driven clinical intelligence platform that enhances every phase of the clinical trial lifecycle by transforming slow, manual processes for protocol development and feasibility assessments into efficient, evidence-based automation. Leveraging insights from approximately one million real-world trials, Aika can swiftly produce first-draft study protocols, comprehensive regulatory documentation, site feasibility evaluations, risk management strategies, and other critical trial components significantly faster than conventional approaches, which helps in minimizing delays and expensive modifications. Aika not only ensures complete transparency in its recommendation processes, allowing teams to confidently communicate their decisions to regulators while retaining expert oversight, but also effectively combines the rapid capabilities of AI with the depth of clinical knowledge. By drastically reducing trial preparation times from weeks to mere days, it significantly decreases the chances of amendments and mitigates overall risk, all while seamlessly fitting into existing workflows without the need for extensive retraining. With Aika, clinical trial teams can focus more on strategic decision-making rather than being bogged down by administrative tasks.
Description
Zenerate is an innovative platform that harnesses artificial intelligence to aid real estate developers, architects, and urban planners in generating optimized building and site plans in real-time, tailored to specific project goals. By simply entering essential parameters, users can quickly access a range of design options that adhere to requirements such as Floor Area Ratio (FAR) and density limits. The platform also allows for manual adjustments to floor plans, making it possible to customize elements like corridors, vertical cores, and unit layouts to accommodate site-specific challenges. Zenerate’s advanced engine encourages thorough exploration of all development possibilities, helping users identify the most effective use of any given site. This all-encompassing methodology not only streamlines the design process but also significantly cuts down the time required for feasibility assessments. Furthermore, it enhances strategic decision-making by delivering data-driven insights into potential returns and the overall viability of projects, ensuring that developers can make informed choices. Ultimately, Zenerate empowers users to maximize their project's potential while minimizing risks and inefficiencies.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Biorce
Founded
2024
Country
Spain
Website
www.biorce.com/our-software
Vendor Details
Company Name
Zenerate
Founded
2020
Country
United States
Website
www.zenerate.ai/
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
No
Document Management
No
Electronic Data Capture
No
Enrollment Management
No
HIPAA Compliant
No
Monitoring
No
Patient Database
No
Recruiting Management
No
Scheduling
No
Study Planning
No